data13F

MRVI – Maravai Lifesciences Hldgs-A

Held by 2 of 60 tracked investors in their latest 13F filing · 1 counted on Most owned (narrow-view filings excluded)

Investors holding2
Combined shares1,914,419
Combined reported value$14.7M

MRVI chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
FPA (First Pacific Advisors) 0.08 884,883$6.8MQ3 2026
Paul Tudor Jones narrow view 0.04 Reduced 44.3%1,029,536$7.9MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Reduced 44.3%1,029,5360.03
Q2 2026Paul Tudor Jones narrow view Added 365.9%1,849,0790.04
Q1 2026Paul Tudor Jones narrow view New396,9150.01

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view Added 365.9%1,849,0790.04
Q1 2026Paul Tudor Jones narrow view New396,9150.01

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Reduced 44.3%1,029,5360.03

History

2 peakQ3 2026: 2 tracked investors
Q4 2020: 1 tracked investorsQ2 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 2 tracked investorsQ2 2026: 2 tracked investorsQ3 2026: 2 tracked investors
20202026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
FPA (First Pacific Advisors)884.9K884.9K884.9K884.9K884.9K741.3K––
Paul Tudor Jones1.03M1.85M396.9K–––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).